Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 6 | 2024 | 749 | 2.300 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 40 | 0.850 |
Why?
|
| Inflammation Mediators | 1 | 2024 | 409 | 0.790 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2021 | 38 | 0.770 |
Why?
|
| Tachycardia, Ventricular | 1 | 2022 | 206 | 0.710 |
Why?
|
| Heart Failure | 2 | 2024 | 2496 | 0.670 |
Why?
|
| Catheter Ablation | 1 | 2024 | 575 | 0.640 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 505 | 0.630 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 560 | 0.630 |
Why?
|
| beta 2-Microglobulin | 1 | 2019 | 189 | 0.630 |
Why?
|
| Lung Diseases | 1 | 2021 | 753 | 0.510 |
Why?
|
| Quantitative Trait Loci | 4 | 2021 | 337 | 0.500 |
Why?
|
| Inflammation | 1 | 2024 | 2526 | 0.470 |
Why?
|
| Mendelian Randomization Analysis | 4 | 2021 | 79 | 0.430 |
Why?
|
| Blood Pressure | 1 | 2019 | 1593 | 0.420 |
Why?
|
| Proteins | 1 | 2019 | 2047 | 0.360 |
Why?
|
| Lung | 1 | 2021 | 3268 | 0.350 |
Why?
|
| Genome-Wide Association Study | 5 | 2021 | 2083 | 0.270 |
Why?
|
| Tachycardia | 1 | 2024 | 84 | 0.230 |
Why?
|
| Atrial Remodeling | 1 | 2022 | 13 | 0.210 |
Why?
|
| Weightlessness | 1 | 2022 | 57 | 0.200 |
Why?
|
| Cardiovascular Diseases | 3 | 2020 | 2280 | 0.200 |
Why?
|
| Protective Factors | 1 | 2021 | 108 | 0.190 |
Why?
|
| Vital Capacity | 1 | 2021 | 137 | 0.190 |
Why?
|
| Mean Platelet Volume | 1 | 2020 | 5 | 0.190 |
Why?
|
| Space Flight | 1 | 2022 | 129 | 0.180 |
Why?
|
| Blood Proteins | 2 | 2020 | 299 | 0.180 |
Why?
|
| Calcium Signaling | 1 | 2022 | 284 | 0.180 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2020 | 64 | 0.180 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2022 | 240 | 0.180 |
Why?
|
| Peroxidase | 1 | 2020 | 134 | 0.170 |
Why?
|
| Respiratory Function Tests | 1 | 2021 | 353 | 0.170 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 320 | 0.170 |
Why?
|
| Platelet Count | 1 | 2020 | 490 | 0.170 |
Why?
|
| DNA Methylation | 2 | 2019 | 2743 | 0.160 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 149 | 0.160 |
Why?
|
| Second Messenger Systems | 1 | 2018 | 37 | 0.150 |
Why?
|
| Fimbriae, Bacterial | 1 | 2018 | 71 | 0.150 |
Why?
|
| Bacterial Adhesion | 1 | 2018 | 152 | 0.140 |
Why?
|
| Humans | 15 | 2024 | 270825 | 0.140 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 706 | 0.140 |
Why?
|
| Cyclic AMP | 1 | 2018 | 404 | 0.140 |
Why?
|
| Biofilms | 1 | 2018 | 203 | 0.130 |
Why?
|
| Calcium | 1 | 2022 | 1597 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 499 | 0.130 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2018 | 251 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2019 | 374 | 0.130 |
Why?
|
| Lipids | 1 | 2019 | 659 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 5436 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 761 | 0.120 |
Why?
|
| Animals | 5 | 2024 | 62801 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 1293 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 4495 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 1467 | 0.100 |
Why?
|
| Mice | 3 | 2023 | 36026 | 0.100 |
Why?
|
| Biomarkers | 2 | 2020 | 5102 | 0.100 |
Why?
|
| Disease Progression | 1 | 2022 | 6892 | 0.090 |
Why?
|
| Genomics | 1 | 2021 | 2818 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 7465 | 0.080 |
Why?
|
| Hypertension | 1 | 2019 | 1613 | 0.080 |
Why?
|
| Middle Aged | 6 | 2021 | 90030 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2024 | 12206 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 7220 | 0.070 |
Why?
|
| CpG Islands | 2 | 2019 | 653 | 0.070 |
Why?
|
| Adult | 4 | 2021 | 81540 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2019 | 2908 | 0.070 |
Why?
|
| Male | 6 | 2021 | 128398 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 2046 | 0.060 |
Why?
|
| Female | 6 | 2021 | 148456 | 0.060 |
Why?
|
| Bed Rest | 1 | 2022 | 18 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 115 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2024 | 33821 | 0.050 |
Why?
|
| Astronauts | 1 | 2022 | 58 | 0.050 |
Why?
|
| Mutation | 1 | 2022 | 15859 | 0.050 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2022 | 65 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 296 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2023 | 165 | 0.050 |
Why?
|
| Heart Atria | 1 | 2023 | 357 | 0.050 |
Why?
|
| Megakaryocyte Progenitor Cells | 1 | 2020 | 10 | 0.050 |
Why?
|
| CD146 Antigen | 1 | 2020 | 57 | 0.050 |
Why?
|
| Aged | 3 | 2021 | 73188 | 0.050 |
Why?
|
| Megakaryocytes | 1 | 2020 | 131 | 0.040 |
Why?
|
| Menarche | 1 | 2019 | 50 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 1 | 2020 | 104 | 0.040 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 192 | 0.040 |
Why?
|
| Epigenomics | 1 | 2019 | 268 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2019 | 287 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2020 | 834 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 4326 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 532 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 675 | 0.030 |
Why?
|
| Risk | 1 | 2020 | 1913 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2022 | 1192 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 1585 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 2214 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 17814 | 0.020 |
Why?
|
| Genome, Human | 1 | 2019 | 1834 | 0.020 |
Why?
|
| Transcriptome | 1 | 2019 | 1933 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2020 | 4190 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 6464 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 6828 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 5163 | 0.020 |
Why?
|